Clincosm LogoSign in Get a demo

squamous cell carcinoma of head and neck

Showing 1 - 25 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Head and Neck Squamous-cell Carcinoma

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
    • (no location specified)
    Nov 5, 2023

    Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,

    Not yet recruiting
    • Head and Neck Cancer
    • +2 more
    • Chicago, Illinois
      University of Chicago Medicine Comprehensive Cancer Center
    Oct 25, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • fMRI
    • Oral Pimonidazole
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Center
    Oct 9, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Hangzhou, Zhejiang, China
      Department of Medical Onocology, First Affiliated Hospital of Zh
    Oct 7, 2023

    Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

    Not yet recruiting
    • Head Neck
    • Squamous Cell Carcinoma of Head and Neck
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 14, 2023

    Needs and Preferences of Patients With Head-neck Cutaneous SCC

    Active, not recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +10 more
    • Regular care with additional administration of a semi-structured interview
    • Maastricht, Netherlands
      Maastricht University Medical Center+
    Sep 13, 2023

    Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +10 more
    • Los Angeles, California
    • +4 more
    Sep 5, 2023

    Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

    Not yet recruiting
    • Carcinoma
    • +7 more
    • XNW5004
    • Pembrolizumab 25 mg/mL Solution for Injection
    • (no location specified)
    Aug 31, 2023

    Squamous Cell Carcinoma of Head and Neck Trial (0.5 mL Candin®/injection, Placebo: 0.5 mL Intravenous 0.9% NaCl solution

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • 0.5 mL Candin®/injection
    • Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)
    • (no location specified)
    Jul 17, 2023

    Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Basal Cell Carcinoma of Skin
    • microscopy confocal (Histolog Scanner)
    • Vandœuvre-lès-Nancy, France
      Gilles Dolivet
    Jul 7, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Houston, Texas
      M D Anderson Cancer Centerl
    Apr 25, 2023

    Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

    Recruiting
    • Head and Neck Cancer
    • Squamous Cell Carcinoma of Head and Neck
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Apr 24, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Italy (Nivolumab 240 MG in 24 ML Injection)

    Completed
    • Squamous Cell Carcinoma of Head and Neck
    • Nivolumab 240 MG in 24 ML Injection
    • Bergamo, Italy
    • +22 more
    Apr 4, 2023

    Squamous Cell Carcinoma of Head and Neck, Chemo Induced Nausea and Vomiting Trial (nurse-led standardized intervention)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Chemotherapy Induced Nausea and Vomiting
    • nurse-led standardized intervention
    • (no location specified)
    Mar 29, 2023

    Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +2 more
    • RP3
    • +3 more
    • (no location specified)
    Feb 21, 2023

    MicroRNA Markers in Head and Neck Cancers

    Active, not recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Tissue collection
    • Aurora, Colorado
      University of Colorado Cancer Center
    Feb 1, 2023

    Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

    Recruiting
    • Uterine Cervical Neoplasms
    • +10 more
    • Pembrolizumab/Vibostolimab Co-Formulation
    • +11 more
    • Anchorage, Alaska
    • +65 more
    Jan 27, 2023

    Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • +4 more
    • AB248
    • Pembrolizumab
    • Lafayette, Indiana
    • +2 more
    Jan 25, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in France, Spain, United States (Setanaxib, Pembrolizumab, Placebo)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Miami Beach, Florida
    • +28 more
    Jan 19, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (SI-B001, SI-B003)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Shanghai, Shanghai, China
      Shanghai Oriental Hospital
    Jan 13, 2023

    Colorectal Cancer, Gastric Cancer, HER2-negative Breast Cancer Trial (TOS-358)

    Not yet recruiting
    • Colorectal Cancer
    • +8 more
    • (no location specified)
    Jan 5, 2023

    Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

    Not yet recruiting
    • Colorectal Cancer Metastatic
    • Squamous Cell Carcinoma of Head and Neck
    • WU-NK-101 - Dose Escalation
    • +3 more
    • (no location specified)
    Dec 30, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Camrelizumab+cetuximab+chemo)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Shanghai, China
      Fudan University
    Jan 4, 2023

    Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

    Recruiting
    • Solid Tumor
    • +8 more
    • TPST-1495 twice daily
    • +2 more
    • Baltimore, Maryland
    • +8 more
    Jan 4, 2023